Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Perri

Showing results (211-220 of 229) with videos related to

Pageof 23
Sort By:
Cancers|November 13, 2025
Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal CancersMaurizio Capuozzo, Carmine Picone, Francesco Sabbatino, et al.
BMC Cancer|November 26, 2016
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trialFrancesco Caponigro, Elena Di Gennaro, Franco Ionna, et al.
Gut|February 14, 2023
Gut virome-colonising <i>Orthohepadnavirus</i> genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation <i>in vivo</i>Luca Massimino, Orazio Palmieri, Amanda Facoetti, et al.
Therapeutic Advances in Medical Oncology|April 15, 2021
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocolAlessandro Ottaiano, Stefania Scala, Mariachiara Santorsola, et al.
Inflammatory Bowel Diseases|August 24, 2018
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across ItalyAlessandro Armuzzi, Gionata Fiorino, Angela Variola, et al.
Neoplasia (New York, N.Y.)|December 22, 2024
Clinical and genetic drivers of oligo-metastatic disease in colon cancerAlessandro Ottaiano, Mariachiara Santorsola, Roberto Sirica, et al.
Cancers|March 29, 2023
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New PerspectivesAlessandro Ottaiano, Mariachiara Santorsola, Luisa Circelli, et al.
Cancers|August 27, 2021
Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 StudyAlessandro Ottaiano, Angela Petito, Mariachiara Santorsola, et al.
International Journal of Cancer|December 1, 2022
Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer riskMatteo Giaccherini, Riccardo Farinella, Manuel Gentiluomo, et al.
Carcinogenesis|September 6, 2023
A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinomaMatteo Giaccherini, Leonardo Gori, Manuel Gentiluomo, et al.
Pageof 23

Showing results (211-220 of 229) with videos related to

Sort By:
Pageof 23
Cancers|November 13, 2025
Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal CancersMaurizio Capuozzo, Carmine Picone, Francesco Sabbatino, et al.
BMC Cancer|November 26, 2016
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trialFrancesco Caponigro, Elena Di Gennaro, Franco Ionna, et al.
Gut|February 14, 2023
Gut virome-colonising <i>Orthohepadnavirus</i> genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation <i>in vivo</i>Luca Massimino, Orazio Palmieri, Amanda Facoetti, et al.
Therapeutic Advances in Medical Oncology|April 15, 2021
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocolAlessandro Ottaiano, Stefania Scala, Mariachiara Santorsola, et al.
Inflammatory Bowel Diseases|August 24, 2018
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across ItalyAlessandro Armuzzi, Gionata Fiorino, Angela Variola, et al.
Neoplasia (New York, N.Y.)|December 22, 2024
Clinical and genetic drivers of oligo-metastatic disease in colon cancerAlessandro Ottaiano, Mariachiara Santorsola, Roberto Sirica, et al.
Cancers|March 29, 2023
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New PerspectivesAlessandro Ottaiano, Mariachiara Santorsola, Luisa Circelli, et al.
Cancers|August 27, 2021
Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 StudyAlessandro Ottaiano, Angela Petito, Mariachiara Santorsola, et al.
International Journal of Cancer|December 1, 2022
Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer riskMatteo Giaccherini, Riccardo Farinella, Manuel Gentiluomo, et al.
Carcinogenesis|September 6, 2023
A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinomaMatteo Giaccherini, Leonardo Gori, Manuel Gentiluomo, et al.
Pageof 23